louisakewell, Author at European Medical Journal - Page 118 of 153

Continue
EMJ
2 Mins
22nd May 2015

Data Presented on Orsiro Hybrid Drug – El uting Stent at EuroPCR 2015 Highlights Safety and Efficacy in High – Risk Patients

PARIS, France, May 20, 2015—BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, today hosted a…
EMJ
21st May 2015

PARP inhibitors and the EMBRACA study of talazoparib in BRCA-related metastatic breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof. Dr. med. Peter Fasching (Friedrich-Alexander-Universität Erlangen-Nürnberg…
EMJ
21st May 2015

The mechanisms of BRCA-related breast cancer and molecular profiling

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof. Dr. med. Michael Untch (HELIOS Klinikum Berlin-Buch, Berlin, Germany) and Prof…
EMJ
21st May 2015

Current research into treatments for BRCA-related breast cancer and the phase 3 EMBRACA trial

Dr Kelly focuses on the phase 3 EMBRACA study, which is evaluating the PARP inhibitor, talazoparib, versus physician’s choice in patients with locally advanced and/or metastatic BRCA-related breast cancer.
EMJ
21st May 2015

The role of BRCA and PARP in DNA repair and BRCA-related breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof. Dr. med. Peter Fasching (Friedrich-Alexander-Universität Erlangen-Nürnberg…
EMJ
21st May 2015

The phase 3 EMBRACA study of talazoparib in BRCA-related metastatic breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof. Dr. med. Michael Untch (HELIOS Klinikum Berlin-Buch, Berlin, Germany) and Prof…
EMJ
4 Mins
18th May 2015

Even Olympic Athletes Have Cardiac Abnormalities and May Be at Risk of Cardiovascular Disease

15 May 2015, Lisbon, Portugal. Even athletes whose performance and fitness are at the very highest level may have life-threatening cardiovascular…
EMJ
4 Mins
18th May 2015

Exercise, However Modest, Found Progressively Beneficial to the Elderly

15 May 2015, Lisbon, Portugal. Even exercise of short duration and low intensity has life expectancy benefits for the elderly. Such conclusions have been…
EMJ
1 Mins
18th May 2015

Are YOU at Increased Risk of Leukaemia?

INCREASED risk of acute lymphoblastic leukaemia (ALL) can be attributed to a genetic mutation in a similar manner to the BRCA1 mutation that can…
EMJ
1 Mins
18th May 2015

Rise in Deadly Skin Cancer is by No Means Old News

SENIOR citizens in Britain are approximately seven times more likely to develop malignant melanoma than they were 40 years ago, according to new statistics.